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Introduction
During development, melanocyte precursors migrate from the 
neural crest toward the epidermis, where they are arrested when 
contacting keratinocytes. Differentiated human melanocytes re-
main strictly localized at the basement membrane and cannot 
survive within the upper epidermal layers unless transformed in 
nevi or melanomas. Keratinocytes control the normal growth of 
melanocytes to maintain a lifelong stable ratio, and they regu-
late the expression of cell surface molecules (Valyi-Nagy et al., 
1993). They also produce growth factors and cytokines that may 
act as paracrine factors to regulate the phenotype of melano-
cytes, including interleukin-1β (IL-1β), TNF-α, stem cell  factor 
(SCF), and EGF (Imokawa, 2004).
CCN3 (nephroblastoma overexpressed) is a matricellular 
protein that shares, with fi  ve other family members, structural 
modules of insulin-like growth factor–binding domains, von 
Willebrand factor type C repeats, thrombospondin type 1 
  repeats, and secreted regulatory factors containing cysteine 
knot motifs for dimerization (Perbal and Takigawa, 2005). 
  Depending on the cell type and tissue context, matricellular pro-
teins participate in diverse functions, such as cell adhesion, 
proliferation, differentiation, and survival (Brigstock, 1999).
In a search for the molecular players involved in cross talk 
between melanocytes and keratinocytes, we compared gene 
 expression  profi  les of melanocytes grown in monoculture with 
melanocytes grown under the control of keratinocytes. We 
found CCN3 protein being up-regulated in melanocytes after 
coculture with keratinocytes. The CCN3 protein was secreted 
into the culture medium and affected two fundamental features 
of melanocytic physiology: it inhibited the proliferation of me-
lanocytes and was required for the 3D organization of the mela-
nocyte network on the basal membrane of human skin equivalent. 
Furthermore, CCN3 stimulated the adhesion of melanocytes to 
basal membrane collagen IV but not to dermal collagen I, as 
confi  rmed by the siRNA-mediated down-regulation of CCN3 
and two-photon (2P) microscopy. We then identifi  ed discoidin 
domain receptor 1 (DDR1), a receptor tyrosine kinase, as being 
responsible for the adhesive properties of CCN3.
Results and discussion
To investigate how keratinocytes change the phenotype of me-
lanocytes, we cocultured pure populations of melanocytes and 
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elanocytes reside within the basal layer of 
the human epidermis, where they attach to the 
basement membrane and replicate at a rate 
proportionate to that of keratinocytes, maintaining a life-
long stable ratio. In this study, we report that cocultur-
ing melanocytes with keratinocytes up-regulated CCN3, 
a matricellular protein that we subsequently found to be 
critical for the spatial localization of melanocytes to the 
basement membrane. CCN3 knockdown cells were dis-
sociated either upward to the suprabasal layers of the epi-
dermis or downward into the dermis. The overexpression 
of CCN3 increased adhesion to collagen type IV, the major 
component of the basement membrane. As the receptor 
responsible for CCN3-mediated melanocyte localization, 
we identiﬁ  ed discoidin domain receptor 1 (DDR1), a re-
ceptor tyrosine kinase that acts as a collagen IV adhesion 
receptor. DDR1 knockdown decreased melanocyte adhe-
sion to collagen IV and shifted melanocyte localization 
in a manner similar to CCN3 knockdown. These results 
demonstrate an intricate and necessary communication 
between keratinocytes and melanocytes in maintaining 
normal epidermal homeostasis.
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keratinocytes and conducted global gene expression analyses of 
monoculture- versus coculture-grown melanocytes. The CCN3 
gene was found to be consistently up-regulated in cocultured 
melanocytes (Fig. 1 A). Keratinocytes in culture or human skin 
did not express CCN3, whereas melanocytes constitutively ex-
pressed it at low levels. After melanocytes were cultured with 
keratinocytes, CCN3 was strongly expressed in the cytoplasm 
of melanocytes and was secreted into the culture medium (Fig. 1, 
B and C). As demonstrated by immunofl  uorescent staining of 
normal human skin, CCN3 was expressed at the basal layer of 
the epidermis, where melanocytes are positioned (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200602132/DC1). 
Keratinocyte-derived culture supernatants stimulated CCN3 
  expression, but the up-regulation of CCN3 by melanocytes 
was strongest when keratinocytes were in direct cell–cell 
contact (Fig. 1 D, fi  rst to third lanes). Coculture with control 
epithelial cells had no effect on CCN3 secretion by melanocytes 
(Fig. 1 D, fourth to seventh lanes).
Keratinocytes commonly express several growth factors 
and cytokines that may change the phenotype of melanocytes. 
TNF-α and IL-1β stimulated the expression of CCN3 (Fig. 1 E). 
IL-1β was constitutively expressed by keratinocytes (unpublished 
data), and TNF-α was found to be undetectable in the culture 
supernatants derived from keratinocytes without stimulation 
(Lan et al., 2005). Therefore, we chose to further investigate the 
effect with IL-1β. Melanocytes began to increase CCN3 secre-
tion 8 h after stimulation by IL-1β, and it continued for 48 h 
(Fig. 1 F). To investigate whether IL-1β produced by keratino-
cytes contributes to the induction and secretion of CCN3, 
we performed immunodepletion of IL-1β in coculture medium 
  using neutralizing antibodies (Fig.1 G). The depletion of IL-1β 
decreased CCN3 in cocultures. However, this inhibiting effect was 
only partial (20% reduction), suggesting that other keratinocyte-
derived factors are involved in the mechanism of CCN3 produc-
tion by melanocytes.
Because CCN3 has antiproliferative activity in  fi  broblastic, 
glioma, and Ewing’s sarcoma cells (Joliot et al., 1992; Fu et al., 
2004; Benini et al., 2005), we sought to determine whether 
CCN3 inhibits the growth of melanocytes. A lentiviral vector 
(si-CCN3-C) designed to knockdown CCN3 in melanocytes 
demonstrated a considerable decrease in protein production 
compared with an empty vector (H1UG-1), a one-pair mismatch 
(si-CCN3-Cm), and two related siRNA (si-CCN3-A and -B) 
vectors in conditioned media (Fig. 2 A) and lysates (not 
depicted). Melanocytes transduced with si-CCN3-C showed in-
creased growth rates compared with cells transduced with con-
trol vectors (Fig. 2 B). The difference in growth rates between 
CCN3 knockdown (si-CCN3-C) and control cells (si-CCN3-Cm) 
was signifi  cant (P = 0.0095) on day 4 after coculture, when 
the medium from si-CCN3-Cm contained more CCN3 than 
si-CCN3-C (Fig. S2 A, available at http://www.jcb.org/cgi/ 
content/full/jcb.200602132/DC1). They also showed a notable 
decrease in attachment to collagen type IV, which is present in 
the basement membrane (Figs. 2 C and S2 B) but not to type I 
collagen present in the dermis (Fig. 2 D) or laminin, which is 
another component of the basement membrane (Fig. S2 C, left). 
This result suggested that CCN3 modulates collagen type IV 
adhesion of melanocytes.
The melanocytes in mouse skin are localized in the dermis, 
suggesting that mouse melanocytes have different regulatory 
Figure 1.  CCN3 expression in melanocytes. (A) Up-
regulated  CCN3 mRNA expression in melanocytes 
in cocultures with keratinocytes as compared with 
monocultures. Results are from quantitative RT-PCR. 
Data represent the mean ± SD (error bars). (B) CCN3 
protein expression in melanocytes in monoculture (mo) 
versus coculture (co). Results are from the Western 
blotting of culture medium (left) with ﬁ  bronectin (FN) 
and Coomassie blue staining (CBB) as loading con-
trols and from cell lysates (right) of two melanocyte cell 
lines (FOM 104 and 105), with β-actin as a loading 
control. (C) Costaining of melanocytes for TYRP1 
(green) and CCN3 (red) shows up-regulation of CCN3 
after coculture with keratinocytes. Colocalization is 
shown in merged photographs of cultures also stained 
with DAPI for the identiﬁ  cation of all nuclei. (D) Immuno-
blot of conditioned medium from monocultured 
  melanocytes (mono), melanocytes cocultured with 
keratinocytes while separated by a semiporous Tran-
swell membrane (Trans-KC), cocultured with keratino-
cytes (coKC), cocultured with HEK 293T cells (co293T), 
cocultured with HEK 293T cells separated by Tran-
swell membrane (Trans-293T), and monocultured HEK 
293T cells (293T). (E) Immunoblot of conditioned me-
dium from melanocytes cocultured with keratinocytes 
(co), monocultured (mono), or monocultured and stim-
ulated with SCF at 50 ng/ml, TNF-α at 100 ng/ml, 
EGF at 20 ng/ml, insulin at 10 nM, or IL-1β at 2 ng/ml 
for 48 h. (F) Immunoblot of conditioned medium from 
monocultured melanocytes treated with 2 ng/ml IL-1β for the times indicated. (G) Immunoblot of conditioned medium from monocultured melanocytes 
treated with 2 μg/ml control goat IgG (mono goat IgG), cocultured melanocytes treated with anti–IL-1β antibodies (co anti IL-1β), and cocultured melano-
cytes treated with 2 μg/ml control goat IgG (co goat IgG). The numbers below the CCN3 blot indicate the relative densities normalized to the ﬁ  bronectin 
blot. (D–G) Fibronectin immunoblot and Coomassie blue staining of Bis-Tris gels were performed as loading controls.CCN3 AND DDR1 MEDIATE MELANOCYTE LOCALIZATION • FUKUNAGA-KALABIS ET AL. 565
mechanisms from humans. The behavior of melanocytes in 
the skin reconstructs resembles that in vivo (Haake and Scott, 
1991; Meier et al., 2000). We further tested the proliferation and 
localization of melanocytes within human skin reconstructs 
(Fig. 2, E–H). To identify melanocytes in sections of skin recon-
structs and to determine their localization by immunohisto-
chemistry, we used a melanocyte-specifi   c marker, HMB-45 
(Fig. 2 E, left). Staining for collagen IV demonstrated the 
  formation of an intact basement membrane within the 14-d skin 
formation period (Fig. 2 E, right). Knockdown of CCN3 in me-
lanocytes increased their numbers and changed their localiza-
tion by migrating either upward to the suprabasal layers of the 
epidermis or downward into the dermis. To better determine the 
cell number and localization of melanocytes within the base-
ment membrane zone, we performed 2P microscopy on the skin 
reconstructs. The lentiviral vectors contained GFP as a marker 
for melanocytes. Second harmonic generation (SHG) signals 
served as a sensitive indicator of collagen I to separate the epi-
thelial layer from underlying stroma (Pena et al., 2005). A com-
bination of 2P-excited GFP and SHG imaging of skin 
reconstructs showed that the knockdown of CCN3 in melano-
cytes not only increased their numbers within the reconstructs 
but also shifted their localization (Fig. 2, F–H). Individual me-
lanocytes separated from the basement membrane, migrated into 
the epidermis, and invaded the dermis (Fig. 2 H). In contrast, 
melanocytes transduced with control vector remained confi  ned 
to the basement membrane zone.
Melanocytes transduced with an adenoviral vector to 
overexpress the CCN3 protein (Fig. 3 A) were growth inhibited 
(Fig. 3 B). Although the CCN family members CCN1 and 
CCN2 have been shown to induce apoptosis (Hishikawa et al., 
1999; Todorovicc et al., 2005), apoptosis as measured by 
  caspase 3 levels was not changed in CCN3-overexpressing 
  melanocytes (Fig. 3 A). There was no increase in the sub-G1 
population of melanocytes overexpressing CCN3 either as 
tested by FACS (unpublished data). Moreover, the cyclin kinase 
inhibitor p21 was up-regulated (Fig. 3 A), suggesting that the 
decrease in proliferation is caused by growth inhibition and not 
cell death. Similar inhibition was seen when recombinant CCN3 
(Li et al., 2002) protein was added to culture medium (Fig. 3 C). 
Melanocytes overexpressing CCN3 increased attachment to 
collagen IV (Fig. 3 D) but not to collagen I (Fig. 3 E) or laminin 
(Fig. S2 C, right). Melanocytes overexpressing CCN3 were 
fi  rmly localized to the basement membrane zone of human skin 
reconstructs. Sections of the reconstructs showed tightly aligned 
melanocytes at the epidermal/dermal interface as assessed 
by melanocyte marker HMB-45 and by collagen IV staining 
(Fig. 3 F). 2P microscopy of skin reconstructs confi  rmed that 
the dendrites of control melanocytes remained separate from 
the basement membrane; however, those overexpressing CCN3 
were localized at the border between the epidermis and dermis 
(Fig. 3, G and H). A limitation of the adenoviral vector system 
is that it is not integrated into the host genomic DNA, and its 
gene expression is extinguished through divisions of host cells. 
Therefore, GFP-positive cells were not observed by 2P imaging 
as frequently as those using a lentiviral vector system. The num-
ber of melanocytes identifi  ed by HMB-45 staining decreased 
when they overexpressed CCN3 (unpublished data). These data 
demonstrate that melanocyte-derived CCN3 inhibits growth to 
maintain normal homeostasis and secures the attachment of 
  melanocytes to the basement membrane.
Because matricellular proteins themselves have only 
weakly adhesive functions (Murphy-Ullrich, 2001), we compared 
the expression profi  le of melanocytes overexpressing CCN3 
with that of control cells by microarray analysis. DDR1 was 
Figure 2.  CCN3 knockdown increases growth and disturbs the localiza-
tion of melanocytes on the basement membrane zone in organotypic cul-
tures of human skin. (A) Immunoblot of conditioned medium from CCN3 
lentiviral siRNA-transfected melanocytes (si-CCN3-A, -B, and -C). Viral 
  vector alone (H1UG-1) and one base pair mismatch siRNA (si-CCN3-Cm) 
were used as controls. Fibronectin blot (FN) and Coomassie blue staining 
(CBB) indicate equal loading. (B) Growth of melanocytes transduced with 
siRNA for CCN3 in coculture with keratinocytes when seeded at a 1:2 
  ratio. Cells were counted on days 1 and 4. n = 4. *, P = 0.0095 when 
compared with si-CCN3-Cm. (C and D) Adhesion on collagen type IV (C) 
and type I (D) as substrates. Data represent the mean ± SD of triplicates. 
*, P = 0.00028. (E) Organotypic cultures of human skin. Immunostaining 
for the melanocyte marker HMB-45 (left; arrows) or the basement mem-
brane protein collagen type IV (COL IV; right). (F) 2P microscopy live 
  images of skin reconstructs at day 14 to visualize melanocytes (green) 
transduced with control lentiviral vector (si-CCN3-Cm) or siRNA CCN3 
(si-CCN3-C). Top view shows x-y view of 3D images, and side view shows 
x-z views of 3D images. (G) Growth of melanocytes transduced with 
siRNA for CCN3 in skin reconstructs at day 14. n = 5. *, P = 0.000014. 
(H) Distribution of melanocytes in skin reconstructs. Level 0 in the y bar 
  indicates the epidermis/dermis border as determined by SHG (blue). 
  Distribution (percentage) = number of melanocytes at each plane/total 
number of melanocytes × 100. n = 5. *, P = 0.024; **, P = 0.0086; 
***, P = 0.014 compared with the control. (B, G, and H) Data represent 
the mean ± SD (error bars).JCB • VOLUME 175 • NUMBER 4 • 2006  566
up-regulated, as verifi  ed by Western blotting in two melano-
cyte cultures when CCN3 was overexpressed (Fig. 4 A). When 
melanocytes were transduced with siRNA against CCN3 
(si-CCN3-C), DDR1 expression was down-regulated. DDR1 
is a tyrosine kinase receptor for several collagens, particularly 
collagen IV (Vogel, 1999). Down-modulation of DDR1 with an 
siRNA, as confi  rmed by Western blotting (Fig. 4 B), showed 
decreased adhesion to collagen IV (Fig. 4 C) similar to those 
from siRNA CCN3. Consistently, adhesion to collagen I was 
not up-regulated (Fig. 4 D). 2P imaging of skin reconstructs 
showed that the knockdown of DDR1 in melanocytes shifted their 
  localization; the proportion of cells at the basement membrane 
zone to total cell number was particularly decreased compared 
with the control (Fig. 4 E). To test whether DDR1 is essential for 
the regulation of melanocyte adhesion to basement membranes 
by CCN3, we overexpressed CCN3 in melanocytes transduced 
with si-DDR1-C. CCN3 overexpression in melanocytes trans-
duced with si-DDR1-C recovered neither adhesion to collagen type 
IV nor normal localization in skin reconstructs (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200602132/DC1), 
confi  rming that up-regulation of the adhesion of melanocytes 
to the basement membrane by CCN3 is mediated through 
the collagen IV receptor DDR1. Knockdown of DDR1 in me-
lanocytes did not increase their number in skin reconstructs 
(Fig. 4 F). Our results suggest that CCN3 regulates melanocyte 
growth through a mechanism that is distinct from adhesion. It 
is possible that CCN3 up-regulates DDR1 expression through 
Figure 3.  Overexpression of CCN3 in melanocytes inhibits growth and 
aligns cells to the basement membrane of skin reconstructs. (A) Immunoblot 
of conditioned medium and cell lysates from melanocytes transduced with 
control GFP and CCN3 adenoviral vector. The samples were harvested 
72 h after infection. β-actin immunoblot indicates equal loading of lysates. 
Fibronectin (FN) immunoblot and Coomassie blue staining (CBB) were 
used as loading controls of conditioned medium. CASP3, caspase 3. The 
numbers below the p21 blot indicate relative density normalized to the 
β-actin blot. (B) Growth of melanocytes transduced with either GFP or CCN3 
using adenoviral vectors. (left) Cell growth was measured by 
3[H]thymidine 
incorporation assays. n = 4. *, P = 0.00079. (right) Cells were counted 
on days 2 and 5. n = 4. *, P = 0.012. (C) Growth of melanocytes in the 
presence of 500 ng/ml CCN3-GST fusion protein or GST control protein. 
*, P = 0.0001. (D and E) Adhesion on collagen type IV (D) and type I (E) 
as substrates. n = 3. *, P = 0.015. (F) Immunostaining of human skin re-
constructs to identify melanocytes using the HMB-45 marker (left; arrows) 
and the basement membrane using collagen type IV (COL IV; right). (G) 2P 
microscopy live images of skin reconstructs to visualize melanocytes (green) 
transduced with control GFP or CCN3 adenoviral vector. Top view shows 
x-y view, and side view shows x-z views of 3D images. White arrows 
  indicate dendrites of melanocytes. (H) Distribution of melanocytes in skin 
reconstructs. Level 0 in the y bar indicates the epidermis/dermis junction 
as  determined by SHG (blue). Distribution (percentage) = number of 
  melanocytes at each level/total number of melanocytes × 100. n = 5. 
*, P = 0.0027. (B, C, and H) Data represent the mean ± SD (error bars).
Figure 4.  DDR1 is modulated by CCN3, and its expression determines the 
adhesion of melanocytes. (A) DDR1 and CCN3 protein expression in mela-
nocytes transduced with GFP or CCN3 for overexpression using an adeno-
viral vector (left two columns) or siRNA CCN3 for knockdown using a 
lentiviral vector (right two columns). Results of cell lysates from two cell lines 
with β-actin as a loading control. (B) DDR1 expression and CCN3 expres-
sion in lysates of melanocytes transduced with DDR1 lentiviral siRNA of 
two different target sequences (si-DDR1-B and -C) and viral vector alone 
(HIUG-1). β-actin immunoblots indicate equal loading. (C and D) Adhesion 
of melanocytes transduced with DDR1 siRNA analyzed on collagen type IV (C) 
and type I (D) as substrates. n = 3. *, P = 0.00075 compared with 
si-DDR1-B. (E) 2P microscopy x-z views of skin reconstructs at day 14 to 
visualize the localization of melanocytes (green) transduced with control 
lentiviral vector (H1UG-1) or siRNA DDR1 (si-DDR1-C). Level 0 in the y bar 
indicates the epidermis/dermis border as determined by SHG (blue). 
Distribution (percentage) = number of melanocytes at each plane/total 
number of melanocytes × 100. n = 5. *, P = 0.0026. (F) Growth of 
  melanocytes transduced with siRNA for DDR1 in skin reconstructs. n = 5. 
(C–F) Data represent the mean ± SD (error bars).CCN3 AND DDR1 MEDIATE MELANOCYTE LOCALIZATION • FUKUNAGA-KALABIS ET AL. 567
the activation of p53 because p21 is a downstream target of 
p53, was up-regulated in CCN3-treated cells, and DDR1 is 
also one of the transcriptional targets of this tumor suppressor 
(Ongusaha et al., 2003).
Melanocytes appear to have a contingency mechanism 
that is essential for their survival and secures continuous attach-
ment to the basement membrane of the skin. The primary 
mechanism for attachment was thought to be through integrins 
(Sonnenberg et al., 1991), of which the laminin-binding integ-
rin α6β1 was the main candidate (Albelda et al., 1990; Hara 
et al., 1994). Down-modulation of α6 integrin in melanocytes 
does not alter their localization in skin reconstructs  (unpublished 
data), suggesting that α6 integrin is not essential for anchor-
age under homeostatic conditions. Because expression of the 
α6-integrin subunit is down-modulated by ultraviolet irradia-
tion (Krengel et al., 2005), the melanocytes must have devel-
oped alternative mechanisms to maintain localization at the 
basement membrane. Our study indicates that CCN3 produc-
tion by melanocytes after their contact with keratinocytes up-
regulates the DDR1 adhesion receptor for collagen IV and 
infl  uences melanocyte localization, contributing to the homeo-
stasis in skin. When the proinfl  ammatory cytokine IL-1β pro-
duced by keratinocytes up-regulates CCN3 in melanocytes, 
their normal localization in the skin is secured through DDR1-
mediated adhesion to collagen type IV. Knockdown of DDR1 
did not affect melanocyte proliferation in skin reconstructs, 
suggesting that there must be other downstream effectors of 
CCN3 that are responsible for the growth inhibitory effect of 
CCN3. Such a mechanism remains to be elucidated. CCN3 can 
bind to αvβ3 (Lin et al., 2003), a multiligand-binding integrin, 
but the β3 subunit is not expressed by normal melanocytes 
(Albelda et al., 1990; Hsu et al., 2000). CCN3 can also bind to 
Notch (Sakamoto et al., 2002); however, Notch signaling is not 
activated in melanocytes (unpublished data). In other cell types, 
CCN3 can be up-regulated by basic FGF (bFGF; Lafont et al., 
2002), which stimulates melanocyte growth but does not modu-
late adhesion. Growth inhibition and basement membrane lo-
calization conferred by CCN3 are important, if not essential, 
functions for maintaining melanocyte homeostasis in the nor-
mal skin. Our fi  ndings suggest that CCN3 dysregulation may 
be the fi  rst step toward disrupting the normal balance between 
melanocytes and keratinocytes. Therefore, clarifying CCN3’s 
role in melanocyte pathogenesis and melanoma is an important 
goal for further work.
Materials and methods
Cell culture
Normal human keratinocytes, melanocytes, and ﬁ  broblasts were isolated 
from neonatal human foreskins. Keratinocytes were cultured in EpiLife me-
dium supplemented with human keratinocyte growth supplement (Cascade 
Biologics, Inc.). Melanocytes were cultured in MCDB153 (Sigma-Aldrich) 
supplemented with 2% FBS, 10% chelated FBS, 2 mM glutamine, 20 pM 
cholera toxin (Sigma-Aldrich), 1.5 nM recombinant human bFGF (Sigma-
Aldrich), 100 nM recombinant human endothelin-3 (Peninsula Labs), and 
10 ng/ml recombinant human SCF (Sigma-Aldrich). Fibroblasts were cul-
tured in DME with 10% FBS. For cocultures, melanocytes were cultured 
with keratinocytes at a 1:5 ratio in EpiLife medium for 2 d. As a control, 
monocultured samples (melanocytes and keratinocytes at a 1:5 ratio) 
were cultured separately for 2 d. For gene expression comparison of 
monocultures with cocultures, melanocytes transduced with GFP were 
  cultured with keratinocytes and isolated by FACS. As required, cells were 
counted or lysed for protein and RNA extraction.
Neutralization of human IL-1𝗃 activity
Cocultures were treated with 2 μg/ml human IL-1β–speciﬁ  c goat IgG (R&D 
Systems) to neutralize IL-1β. Control cultures were treated with 2 μg/ml 
nonspeciﬁ  c goat IgG.
Viral vectors for overexpression and knockdown
The human CCN3 cDNA was ampliﬁ  ed using the primers 5′-G  A  C  G  G  G-
T  A  C  C  T  G  A  G  C  A  T  G  C  A  G  A  G  T  G  T  G  -3′ and 5′-C  T  T  G  T  C  T  A  G  A  A  G  G  T  T  A  C  A  T  T  T-
T  C  C  C  T  C  T  G  G  -3′ and were subcloned into pAdTrack-CMV at KpnI–XbaI 
sites. Recombination between pAdTrack-CMV–CCN3 and pAdEasy was 
performed in Escherichia coli to generate the CCN3 adenoviral vector 
(CCN3/Ad5). The mammalian expression vector H1UG-1 derived from 
the FG12 lentiviral vector (Qin et al., 2003) was used to produce lenti-
viral RNAi vector. DNA sequences encoding siRNA targeting CCN3 and 
DDR1 mRNA were cloned into BamH1 and XhoI sites under control of 
the HuH1 promoter. The original DNA sequences encoding the siRNAs 
targeting CCN3 mRNA were as follows: si-CCN3-A (5′-G  C  T  G  C  A  A  A  T  T  C-
C  A  G  T  G  C  A  C  C  T  -3′), si-CCN3-B (5′-G  T  T  G  A  G  G  T  G  C  C  T  G  G  A  G  A  G  T  -3′), and 
si-CCN3-C (5′-G  T  G  T  C  A  A  C  T  G  C  A  T  T  G  A  A  C  A  -3′). One (si-CCN3-C) out of 
three siRNA vectors displayed high efﬁ  ciency CCN3 knockdown in mela-
nocytes and was selected for the creation of a mutated (indicated in bold) 
control siRNA sequence (si-CCN3-Cm, 5′-G  T  G  T  C  A  A  C  TT  C  A  T  T  G  A  A  C  A  -3′). 
The DNA sequences encoding the siRNAs targeting DDR1 mRNA were 
si-DDR1-B (5′-G  A  G  G  A  G  C  T  G  A  C  G  G  T  T  C  A  C  C  -3′) and si-DDR1-C (5′-G  A  T-
C  T  G  G  T  T  A  G  T  C  T  T  G  A  T  T  -3′). The lentivirus was produced by cotransfection 
of human embryonic kidney 293T cells with four plasmids: a packaging 
defective helper construct, a Rev plasmid, a plasmid coding for a heter-
ologous envelope protein, and the H1UG-1 vector construct harboring the 
selected siRNA sequence.
RNA extraction and gene chip hybridization
Total RNA was isolated using the total RNeasy kit (QIAGEN). Human 
  Genome U133A arrays were used for mRNA expression proﬁ  ling according 
to the manufacturer’s instructions (Affymetrix, Inc.). A laser scanner (Gene-
Array; Hewlett-Packard) was used to analyze gene chips, and the expres-
sion levels were calculated using Microarray Suite software (Affymetrix, 
Inc.). Gene expression values were normalized to the mean value of all 
genes in each experiment.
Quantitative RT-PCR
Total RNA was reverse transcribed into ﬁ  rst-strand cDNA for quantitative 
RT-PCR. The gene speciﬁ  c primers were designed as CCN3 (5′-G  A  A  C  C  G  T-
C  A  A  T  G  T  G  A  G  A  T  G  C  -3′ and 5′-A  C  A  G  A  A  C  C  T  G  G  G  C  T  T  G  T  A  G  G  -3′) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 5′-A  T  G  G  A  A  A  T  C  C-
C  A  T  C  A  C  C  A  T  C  T  T  -3′ and 5′-C  G  C  C  C  C  A  C  T  T  G  A  T  T  T  T  G  G  -3′). ABsolute QPCR 
SYBR Green Mixes (ABgene) were used with 1 ng/ml cDNA and with 70 nM 
of primers for the evaluation of GAPDH and CCN3 expression. A negative 
control without the cDNA template was run with each assay. Ampliﬁ  -
cations were performed in an ABI Prism 7000 Sequence Detection System 
(Applied Biosystems). Thermal cycler conditions were 95°C for 15 min and 
40 cycles of 15 s at 95°C followed by 1 min at 60°C. All experiments were 
performed in triplicate, and a mean value was used for the determination 
of mRNA levels. At the end of PCR, baseline and threshold values (CT) for 
these genes were set using the ABI Prism 7000 software (Applied Biosys-
tems), and the calculated CT values were exported to Excel (Microsoft) for 
analysis. The relative expression of mRNA was calculated using the com-
parative CT method according to the manufacturer (Perkin-Elmer). All sam-
ples were normalized to the relative levels of GAPDH.
CCN3 protein puriﬁ  cation
The CCN3 coding sequence was cloned into the pGEX4T1 vector. Expres-
sion of the recombinant GST-CCN3 protein was induced by adding 0.1 mM 
IPTG to the bacteria cultures when they reached 0.7–0.9 OD at 600 nm. 
After centrifugation, pellets were resuspended in 50 mM Tris, pH 8.0, 
1 mM EDTA, 100 mM NaCl, and proteinase inhibitors (complete cocktail 
[Roche], 200 mM PMSF, 10 mM TLCK, 200 mM benzamidine, and 10 mM 
TPCK), and 300 μg/ml lysozyme was added. Lysis was performed for 
20 min on ice. Triton X-100 was then added to 1%, and lysates were 
  sonicated on ice. After centrifugation, supernatants were incubated with 
glutathione–Sepharose beads (GE Healthcare) in PBS for 1 h at 4°C on a 
rotating wheel. For GST-CCN3, PBS was complemented with 5% fat-free JCB • VOLUME 175 • NUMBER 4 • 2006  568
milk and 0.5 mM ATP. Beads were then washed several times with PBS-
proteinase inhibitors. Recombinant proteins were recovered by three 
  elutions of 1 h on ice with 20 mM glutathione, 100 mM Tris, pH 8.0, and 
120 mM NaCl. Fractions were pooled, dialyzed overnight at 4°C against 
10 mM NH4HCO3, and lyophilized. Quantiﬁ   cation was performed by 
SDS-PAGE and Coomassie blue coloration of the gel.
Immunoassays
For Western analyses to detect CCN3 or DDR1 expression, cells were 
washed with PBS and harvested in radioimmunoprecipitation buffer. To de-
tect secreted CCN3, proteins from conditioned medium corresponding to 
2 × 10
5 melanocytes were collected with heparin–Sepharose beads after 
overnight incubation at 4°C as described previously (Chevalier et al., 
1998). Samples were separated on 4–12% Bis-Tris gels, transferred to 
polyvinylidene diﬂ  uoride membranes, and probed with K19M, antiﬁ  bro-
nectin (Transduction Laboratories), anti–β-actin (Sigma-Aldrich), anti-p21 
(BD Biosciences), anticaspase 3 (Cell Signaling Technology), or anti-DDR1 
antibodies (C-20; Santa Cruz Biotechnology, Inc.). To detect the signal, 
HRP-conjugated secondary antibody was added followed by ECL (GE 
Healthcare). The immunoblot images were acquired with a scanner (Perfection 
636U; Epson) and quantitated using Image Beta 4.02 software (Scion 
Corp.). For immunoﬂ  uorescence, cells were ﬁ  xed, permeabilized, and in-
cubated sequentially with mouse anti-TYRP1 (Signet), FITC-conjugated goat 
anti–mouse IgG, K19M anti-CCN3 rabbit serum, and AlexaFluor594-
  conjugated goat anti–rabbit IgG. Immunoﬂ   uorescent staining was also 
performed on serial sections of human foreskins with K19M and anti-pmel 
17/HMB-45 (DakoCytomation) as primary antibodies. For immunohisto-
chemistry, sections were stained with mouse anti–human type IV collagen 
(Calbiochem) or HMB-45 using standard procedures. Biotin-labeled anti–
mouse secondary antibodies were applied, and signal was detected using 
the ABC kit (Vector Laboratories). After adding 3-amino-9-ethyl carbazole, 
samples were counterstained with Mayer’s hematoxylin (Sigma-Aldrich). 
The immunostaining images were taken by an upright microscope (E600; 
Nikon) with 20/40× objectives. A digital camera (SPOT RT Slider; 
  Diagnostic Instruments) was used to acquire the pictures. Photoshop 6.0 
software (Adobe) was used for contrast and brightness adjustment.
Cell assays
For cell growth experiments, melanocytes were plated in quadruplicates 
in 24-well plates at a density of 5.66 × 10
3 cells/cm
2. Cell growth was 
monitored by counting cells in ﬁ   ve random high power ﬁ   elds. For 
[
3H]thymidine uptake assays, recombinant adenovirus-transduced 
  melanocytes were seeded in quadruplicates in 96-well plates at 5,000 
cells/well 48 h after transduction and cultured in 200 μl of medium. 
  After 24 h, cells were pulsed with 1 μCi [
3H]methyl thymidine and 
  harvested after 12 h for counting.
For adhesion assays, melanocytes were suspended in serum-free 
MCDB153 (6 × 10
5 cells/ml) and transferred in triplicate to either CytoMatrix 
cell adhesion strips coated with human collagen type IV, human laminin 
(Chemicon), or 96-well plates coated with 10 μg/ml bovine type I collagen 
(Organogenesis) and incubated for 90 min at 37°C. After washing to 
  remove unattached cells, the attached cells were stained with 0.2% crystal 
violet. The cell-bound stain was solubilized, and the optical density (570 nm) 
was determined.
Reconstructions of normal human skin were prepared as previously 
reported (Berking et al., 2001). 3 ml of ﬁ  broblast-containing bovine type I 
collagen (7.5 × 10
4 cells/ml) was added to each insert of tissue culture 
trays (Organogenesis) and allowed to constrict in DME with 10% FBS for 
7 d at 37°C. For epidermal reconstruction, keratinocytes were mixed 
with  melanocytes at a ratio of 5:1 in keratinocyte serum-free medium 
  (Invitrogen) containing 2% dialyzed FCS, 60 μg/ml bovine pituitary 
  extract (Invitrogen), 4.5 ng/ml bFGF, 100 nM human endothelin-3, and 
10 ng/ml human SCF. A total of 5 × 10
6 cells were seeded on each con-
tracted collagen gel. Cultures were kept submerged in medium containing 
1 ng/ml EGF for 2 d, 0.2 ng/ml EGF for another 2 d, and were raised to 
the air–liquid interface via feeding from below with high calcium (2.4 mM) 
medium. After 14 d, skin reconstructs were either directly analyzed using 
a 2P microscope or ﬁ  xed with 4% PFA and embedded in parafﬁ  n for sub-
sequent sectioning and staining.
2P imaging was performed with an upright multiphoton micro-
scope (Ultima; Prairie Technologies) attached to a microscope (BX-61; 
Olympus) ﬁ  tted with 20/40× water immersion objectives (Olympus). This 
arrangement was combined with a diode pumped wideband mode-locked 
  titanium-sapphire femtosecond laser (Chameleon; Coherent). Components 
of the extracellular matrix (e.g., collagen) were detected by SHG signals 
(Pena et al., 2005). In all of the experiments, the samples were exposed to 
a wavelength of 920 nm. The wavelengths emitted by the GFP (515 nm) 
and the extracellular matrix (460 nm) were distinguished using a ﬁ  lter cube 
  (Dichroic). Z stacks of a series of x-y planes at a resolution of 2 pixels/μm
−1 
in step size 2 μm were captured using Photonics photomultiplier tubes 
(R3896; Hamamatsu) with ampliﬁ   ers and View acquisition software 
(Prairie Technologies). Volocity software (Improvision) was used to generate 
x-z sections and to render 3D reconstructions of the skin. To assess localiza-
tion of melanocytes in skin reconstructs, ﬁ  ve ﬁ  elds (×200) were randomly 
selected in each reconstruct and scored by counting GFP-positive cells 
on x-y planes at 24-μm intervals. Distribution (percentage) = number of 
melanocytes on each plane/total number of melanocytes on all planes × 100. 
All experiments were performed three times using melanocytes derived 
from three different donors. The data were analyzed by t test (two-tailed 
distribution and two-sample unequal variance) and expressed as the mean 
± SD. Each ﬁ  gure shows one representative experiment.
Online supplemental material
Fig. S1 shows CCN3 expression in human skin. Fig. S2 shows that adhe-
sion on laminin is not affected by CCN3 modulation. Fig. S3 shows that 
the overexpression of CCN3 does not restore the localization of melano-
cytes transduced with si-DDR1. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200602132/DC1.
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